Molbio Diagnostics IPO 2026: Price Band, Dates, Lot Size & Key Details
The Molbio Diagnostics IPO is a mainboard book-built issue that opens on August 10, 2026 and closes on August 12, 2026, with a price band of ₹768 to ₹807 per share and a lot size of 18 shares. This page lists the published terms only. It does not assess whether the issue is suitable for you.
Molbio Diagnostics IPO details at a glance
Figures below are as published in the IPO filing as of early August 2026. Always reconfirm against the offer document and exchange notices before relying on any number.
Detail | Information |
IPO Type | Book-Built Issue (Mainboard) |
Price Band | ₹768 to ₹807 per equity share |
Face Value | ₹1 per equity share |
Lot Size | 18 shares per lot |
Minimum Retail Investment | Approx. ₹14,526 (1 lot at upper price band) |
Maximum Retail Investment | Approx. ₹1,88,838 (13 lots / 234 shares) |
Total Issue Size | Approx. ₹939.70 crore |
Fresh Issue | Approx. ₹200 crore |
Offer for Sale (OFS) | Approx. ₹739.70 crore (91.66 lakh shares) |
Anchor Investor Bidding Date | August 7, 2026 |
IPO Open Date | August 10, 2026 |
IPO Close Date | August 12, 2026 |
Basis of Allotment | August 13, 2026 |
Listing Date (Tentative) | August 17, 2026 |
Listing Exchanges | BSE and NSE |
Investor Quota | QIB: 50% | NII/HNI: 15% | Retail: 35% |
What one lot actually costs
A retail applicant must bid for at least one lot. At the upper end of the price band, ₹807, one lot of 18 shares works out to approximately ₹14,526. Since bids at the cut-off price are made at the upper band, it is sensible to plan for this higher amount rather than the lower end of ₹768. Retail investors can bid up to a maximum of 13 lots, or 234 shares, which comes to roughly ₹1,88,838 at the upper price band.
Fresh issue vs offer for sale: what the money is used for
This IPO combines two components. The fresh issue portion, worth approximately ₹200 crore, involves the company creating new shares, with proceeds going directly to the company for its own use, such as research, manufacturing, or general corporate purposes. The offer-for-sale (OFS) portion, worth approximately ₹739.70 crore, involves existing shareholders selling part of their holding; those proceeds go to the selling shareholders, not the company itself.
How the application process works
For a first-time applicant, the process is done digitally through a broker or bank, and follows a standard sequence:
• Log in to your broker's app or your bank's net banking portal that offers IPO applications.
• Select the IPO from the list of currently open issues.
• Enter the number of lots you wish to bid for and choose a price within the band, or select the cut-off price option.
• Provide your UPI ID (if applying via UPI) or use ASBA through net banking.
• Approve the UPI mandate request in your UPI app to block the required funds.
• Funds are only blocked, not debited, until allotment. If shares are not allotted, the blocked amount is released back to you.
IPO timeline
• Anchor investor bidding: August 7, 2026
• Issue opens: August 10, 2026
• Issue closes: August 12, 2026
• Basis of allotment finalised: August 13, 2026
• Refunds / unblocking of funds and demat credit: on or around August 14, 2026
• Expected listing: August 17, 2026
Dates are indicative and are frequently revised by the issuer, registrar, or exchanges.
A quick snapshot of the business
For context, the company operates in the point-of-care molecular diagnostics space, offering portable testing devices and disease-specific test kits used to detect infections such as tuberculosis, COVID-19, hepatitis, HIV, and other conditions. It has reported growth in both revenue and profit over the last financial year, which is one of several factors — alongside valuation, industry outlook, and business risk — that are typically studied while evaluating any IPO.
Frequently Asked Questions
Ques: What is the Molbio Diagnostics IPO price band?
Ans: The published price band is ₹768 to ₹807 per equity share.
Ques: What is the lot size for this IPO?
Ans: One lot consists of 18 shares. At the upper price band, this works out to approximately ₹14,526 for the minimum retail application.
Ques: When does the Molbio Diagnostics IPO open and close?
Ans: The issue opens on August 10, 2026 and closes on August 12, 2026.
Ques: When is the allotment date and listing date?
Ans: The basis of allotment is expected to be finalised on August 13, 2026, with listing tentatively scheduled for August 17, 2026 on the BSE and NSE.
Ques: What is the total issue size, and how is it structured?
Ans: The total issue size is approximately ₹939.70 crore, comprising a fresh issue of about ₹200 crore and an offer for sale of about ₹739.70 crore.
Ques: What is the maximum number of lots a retail investor can apply for?
Ans: Retail investors can apply for a maximum of 13 lots, equal to 234 shares, which comes to approximately ₹1,88,838 at the upper price band.
Ques: Can I apply using UPI?
Ans: Yes. Retail applications can be made using UPI through a broker, or via ASBA through net banking. In both cases, funds are blocked rather than debited until allotment is finalised.
Ques: Should I apply to this IPO?
Ans: This page does not make that call. It sets out the published terms so you can read the offer document and evaluate it independently, or consult a SEBI-registered investment adviser.
Ques: Is IPO allotment guaranteed if I apply?
Ans: No. Allotment is not guaranteed, particularly if the issue is oversubscribed. Shares are allotted through a lottery-based or proportionate process depending on the investor category.
Disclaimer:
This is written for educational and informational purposes only. Nothing here constitutes investment advice or a recommendation to buy or sell securities. All data is sourced from publicly available information. Investments in securities markets are subject to market risks — please read all offer documents carefully before investing.